Dr. Kumar Siva Kalapatapu, MD

Dr. Kalapatapu practices at NewYork-Presbyterian Westchester in Bronxville, New York.

Dr. Kalapatapu's NPI, 1154324127, was assigned on May 24, 2005. Dr. Kalapatapu graduated from Guntur Medical College NTR in 1985. Dr. Kalapatapu holds New York license 207037.

Dr. Kalapatapu's primary practice is NewYork-Presbyterian Westchester, at 55 Palmer Ave, Bronxville, NY 10708. The practice phone is (914) 787-5008.

Dr. Kalapatapu's primary practice is NewYork-Presbyterian Westchester in Bronxville, New York. Dr. Kalapatapu is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Kalapatapu to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalapatapu practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Kalapatapu's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Kalapatapu is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Kalapatapu's licenses on file in 3 states: New York, Connecticut and Illinois.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Kalapatapu treats.

CMS data shows 967 Medicare services from Dr. Kalapatapu across 10 procedure codes in 2024, for 330 Medicare patients. Medicare paid $107,591 for them.

CMS counts 330 Medicare patients who saw Dr. Kalapatapu in 2024. The largest group is 75 to 84, with 160 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kalapatapu's median patient age at 70, with 40% women.

In 2024, Dr. Kalapatapu wrote 2,470 Medicare Part D claims for 238 patients. 90% of them were for generic drugs. CMS names the drug for 2,234 of them, across 45 drugs with 11 or more claims each, at $273,898 in total drug cost. In 2023, CMS named 2,040 claims across 44 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kalapatapu for performance year 2024, reported through an alternative payment model (APM). Dr. Kalapatapu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 59 procedures of coronary angioplasty and stenting by Dr. Kalapatapu, more than 88% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Kalapatapu, published from 2006 to 2016. 2009 was the busiest year, with 4. The most frequent topics are Angioplasty, Balloon, Coronary, Myocardial Infarction and Coronary Artery Disease. Dr. Kalapatapu has published most often in Am J Cardiol. Dr. Kalapatapu's most frequent co-authors are Anthony L. Pucillo, MD, Chandrasekar Palaniswamy, MD and Hajir Ely Dilmanian, MD.

CMS Open Payments shows 640 general payments to Dr. Kalapatapu from 50 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Boston Scientific Corporation paid the most, $7,296.

Dmand AI lists 1 award for Dr. Kalapatapu.

Dr. Kalapatapu graduated from Guntur Medical College NTR in 1985.

Dr. Kalapatapu is in network with 17 carriers, including Elevance, Aetna and MVP Health Care. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.